Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 1 Patient risk factors
From: Can a combination of different risk factors be correlated with leg fracture healing time?
Patient history factors | Age; sex; height; weight; smoking status (amount and since when); diabetes; malnutrition; abuse (alcohol, narcotics, etc.); drugs used (antibiotics, NSAIDs, corticosteroids, other, specifying the active principle and dosage); associated pathologies; previous surgery |
Fracture morphology | Date of trauma; site (tibia, fibia, tibia and fibia), level (proximal or distal), and lesion zone (epiphysis, metaphysis, diaphysis); side of fracture (right or left); AO classification; type of trauma (high/low energy, details on origin of trauma); type of fracture (closed, exposed <5 cm, exposed >5 cm, open grade I); loss of bone (and details); associated lesions (cutaneous, nervous, tendon, muscular, vascular, none, others); blood loss and hemoglobin value in blood; previous interventions at lesion site (and details); presence of synthesis device at time of trauma; alignment, stability and diastasis between stumps (2, 4, 6, 8, 10 mm) before treatment |
Treatment of fracture | Date of orthopedic treatment; treatment (surgical or conservative); conservative treatment details (cast, brace, other); surgical treatment details (mini-invasive surgery); synthesis device (external fixator, endomedullary nail, plate, locking compression plate, other); further treatment for stabilization (cast, brace, other, none); treatment with autologous bone grafts, homoplastic grafts, stem cells, mesenchymal cells, saw bone, platelet gel, other, none; length of surgery (<200 or >200 min); intraoperative complications (cutaneous, nervous, tendon, vascular, bone, none, other); blood loss and hemoglobin count; complications immediately after operation (24 h); administration of drugs after treatment (antibiotics, NSAIDs, corticosteroids, other, specifying active principle and dosage); thrombo-embolism prophylaxis; alignment, stability and minimum diastasis between stumps (2, 4, 6, 8, 10 mm) after treatment; biophysical therapy (details, start date) at follow-up; drugs used at follow-up (antibiotics, NSAIDs, corticosteroids, other, specifying active principle and dosage); infection at follow-up; removal of fixing device at follow-up; removal of fixing device at follow-up; new treatment (surgical or conservative) at follow-up at the lesion site; re-fracture at follow-up at the lesion site; alignment, stability and minimum diastasis between stumps (2, 4, 6, 8, 10 mm) at follow-up; clinical healing at follow-up (patient has no functional limitation) |